Hexima Returns Capital to Shareholders and Posts Modest Quarterly Cash Outflow
Hexima Clears Approval Condition for Cash Return of Capital
Hexima Secures Shareholder Approval for Security Reorganisation
Hexima Shareholders Back Return of Capital in Decisive Vote
Hexima to Consolidate Ordinary Shares Following Shareholder Approval
Hexima Announces Cash Return of Capital to Shareholders
Hexima Sets April Vote on $1 Million Capital Return and Share Cancellation
Hexima Narrows Half-Year Loss but Maintains Capital-Conserving Stance
Hexima Preserves $1.4m Cash as It Weighs Capital Return to Shareholders
ASX Warns Long-Term Suspended Companies of Reporting Deadlines and Delisting Risk
Hexima Ltd Announces Successful AGM Results
Hexima Ltd Outlines Future Amidst Clinical Setbacks
Hexima Limited Explores Strategic Opportunities Amid Quarterly Financial Update
Hexima Ltd: 2025 Annual Report
Hexima Ltd: Appendix 4D & Interim Financial Report
Hexima Ltd Announces Cessation of Securities Options
Hexima Ltd Cancels Acquisition, Explores New Opportunities
Hexima Ltd Cancels Planned Share Consolidation
Hexima Ltd Reveals Corporate Governance Statement
Hexima Ltd: 2024 Annual Report